Arild Holth

1.3k total citations
54 papers, 1.1k citations indexed

About

Arild Holth is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arild Holth has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arild Holth's work include Ovarian cancer diagnosis and treatment (12 papers), Cancer Cells and Metastasis (9 papers) and Endometrial and Cervical Cancer Treatments (7 papers). Arild Holth is often cited by papers focused on Ovarian cancer diagnosis and treatment (12 papers), Cancer Cells and Metastasis (9 papers) and Endometrial and Cervical Cancer Treatments (7 papers). Arild Holth collaborates with scholars based in Norway, Israel and United States. Arild Holth's co-authors include Ben Davidson, Claes G. Tropé, Hiep Phuc Dong, Bjørn Risberg, Reuven Reich, Aasmund Berner, Lilach Kleinberg, Viví Ann Flørenes, Mari Bunkholt Elstrand and Dag André Nymoen and has published in prestigious journals such as Scientific Reports, Molecular Cancer and Human Pathology.

In The Last Decade

Arild Holth

51 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arild Holth Norway 20 512 373 303 180 175 54 1.1k
Yvonne T.M. Tsang United States 18 533 1.0× 329 0.9× 211 0.7× 166 0.9× 141 0.8× 24 1.2k
Jan Dominik Kuhlmann Germany 18 510 1.0× 446 1.2× 486 1.6× 185 1.0× 131 0.7× 62 1.1k
Jari Sundström Finland 22 484 0.9× 520 1.4× 332 1.1× 154 0.9× 295 1.7× 49 1.2k
A. Reza Radjabi United States 8 793 1.5× 287 0.8× 569 1.9× 143 0.8× 74 0.4× 9 1.3k
Tsutomu Imai Japan 8 595 1.2× 330 0.9× 316 1.0× 75 0.4× 61 0.3× 15 900
Julie Koeman United States 20 923 1.8× 365 1.0× 462 1.5× 93 0.5× 286 1.6× 26 1.5k
Chenfei Zhou China 22 786 1.5× 581 1.6× 512 1.7× 329 1.8× 188 1.1× 68 1.5k
Ivraym B. Barsoum Canada 12 525 1.0× 548 1.5× 452 1.5× 537 3.0× 171 1.0× 15 1.4k
Minhong Shen China 16 643 1.3× 370 1.0× 243 0.8× 207 1.1× 93 0.5× 25 1.3k
Evelyn N. Garrett United States 10 461 0.9× 142 0.4× 147 0.5× 205 1.1× 97 0.6× 11 929

Countries citing papers authored by Arild Holth

Since Specialization
Citations

This map shows the geographic impact of Arild Holth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arild Holth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arild Holth more than expected).

Fields of papers citing papers by Arild Holth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arild Holth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arild Holth. The network helps show where Arild Holth may publish in the future.

Co-authorship network of co-authors of Arild Holth

This figure shows the co-authorship network connecting the top 25 collaborators of Arild Holth. A scholar is included among the top collaborators of Arild Holth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arild Holth. Arild Holth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davidson, Ben, Arild Holth, Jeremias Wohlschlaeger, Maurizio Pinamonti, & Binnur Önal. (2025). The Diagnostic Role of TFF1, TFF3, FOXA1, CA XII and TRPS1 in Serous Effusions. Cytopathology. 36(4). 408–417. 1 indexed citations
2.
Davidson, Ben, Daniel Nebdal, Arild Holth, et al.. (2024). Endometrial carcinomas with ambiguous histology often harbor TP53 mutations. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 486(4). 697–705. 1 indexed citations
3.
Bischof, Katharina, Arild Holth, Assia Bassarova, & Ben Davidson. (2024). Expression of PRAME in high-grade serous carcinoma is associated with higher residual disease volume and Occludin expression. Pathology - Research and Practice. 266. 155787–155787.
4.
Davidson, Ben, et al.. (2023). Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 482(6). 975–982. 6 indexed citations
5.
Davidson, Ben, Arild Holth, & Hiep Phuc Dong. (2020). Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 477(5). 677–685. 1 indexed citations
6.
Davidson, Ben, et al.. (2020). Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 477(6). 857–864. 6 indexed citations
7.
Dominguez–Valentin, Mev, Sigve Nakken, Hélène Tubeuf, et al.. (2019). Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing. Scientific Reports. 9(1). 18555–18555. 12 indexed citations
8.
Onallah, Hadil, et al.. (2019). SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma. Gynecologic Oncology. 153(3). 651–660. 29 indexed citations
9.
Panagopoulos, Ioannis, Ludmila Gorunova, Kristin Andersen, et al.. (2019). Chromosome Translocation t(14;21)(q11;q22) Activates Both OLIG1 and OLIG2 in Pediatric T-cell Lymphoblastic Malignancies and May Signify Adverse Prognosis. Cancer Genomics & Proteomics. 17(1). 41–48. 2 indexed citations
10.
Davidson, Ben, et al.. (2018). Expression, activation and clinical relevance of CHK1 and CHK2 in metastatic high-grade serous carcinoma. Gynecologic Oncology. 150(1). 136–142. 2 indexed citations
11.
Davidson, Ben, et al.. (2017). TGFβ splicing and canonical pathway activation in high-grade serous carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 470(6). 665–678. 2 indexed citations
12.
Davidson, Ben, Maurizio Pinamonti, Arild Holth, et al.. (2017). The diagnostic role of PTEN and ARID1A in serous effusions. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 472(3). 425–432. 5 indexed citations
13.
Davidson, Ben, et al.. (2014). VICKZ2 protein expression in ovarian serous carcinoma effusions is associated with poor survival. Human Pathology. 45(7). 1520–1528. 15 indexed citations
14.
Stavnes, Helene Tuft, Arild Holth, J. Kærn, et al.. (2013). HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival. Gynecologic Oncology. 129(2). 358–363. 23 indexed citations
15.
Stavnes, Helene Tuft, et al.. (2012). AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 462(2). 163–173. 8 indexed citations
16.
Davidson, Ben, Arild Holth, Mai T. Nguyen, Claes G. Tropé, & Chuanyue Wu. (2012). Migfilin, α-parvin and β-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases. Gynecologic Oncology. 128(2). 364–370. 6 indexed citations
17.
Davidson, Ben, Vera M. Abeler, Arild Holth, et al.. (2012). Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma. Gynecologic Oncology. 128(2). 349–355. 37 indexed citations
18.
Hetland, Thea Eline, Dag André Nymoen, Arild Holth, et al.. (2012). Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance. Human Pathology. 44(5). 777–785. 19 indexed citations
19.
Davidson, Ben, et al.. (2011). Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome. Human Pathology. 42(7). 991–997. 7 indexed citations
20.
Davidson, Ben, Helene Tuft Stavnes, Arild Holth, et al.. (2010). Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions. Journal of Cellular and Molecular Medicine. 15(3). 535–544. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yvonne T.M. Tsang Breakdown of academic impact, for papers by Jan Dominik Kuhlmann Breakdown of academic impact, for papers by Jari Sundström Breakdown of academic impact, for papers by A. Reza Radjabi Breakdown of academic impact, for papers by Tsutomu Imai Breakdown of academic impact, for papers by Julie Koeman Breakdown of academic impact, for papers by Chenfei Zhou Breakdown of academic impact, for papers by Ivraym B. Barsoum Breakdown of academic impact, for papers by Minhong Shen Breakdown of academic impact, for papers by Evelyn N. Garrett
Rankless by CCL
2026